- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01237886
Weaning And Variability Evaluation (WAVE)
July 5, 2017 updated by: Ottawa Hospital Research Institute
Knowing when to liberate patients from mechanical ventilation (i.e.
removal of breathing or endotracheal tube or extubation) is critically important, as both prolonged ventilation and failed extubation are both associated with harm and risk of death.
Our objective is to improve the safety of extubation by harnessing hidden information contained in the patterns of variation of heart and respiratory rate measured over intervals-in-time.
Currently, to assess a patient's ability to be extubated, a spontaneous breathing trial (SBT) is routinely performed, where the level of ventilator support is reduced, and their response is observed in order to help predict if they will tolerate extubation (i.e.
complete removal of ventilator support).
Given that health is associated with a high degree of variation of physiologic parameters (e.g.
heart and respiratory rate), and illness & stress are associated with a loss of variability, the investigators aim to uncover the loss of variation as a measure of stress during SBT's.
The investigators hypothesize that maintaining stable heart rate and respiratory rate variability (HRV and RRV) throughout the SBT will predict subsequent successful extubation, and conversely, a reduction in either HRV or RRV manifest during a SBT predicts extubation failure.
A pilot study has demonstrated feasibility, and compelling preliminary results.
A website, centralized data storage and analysis, and a trans-disciplinary team of scientists are in place to definitively test this novel technology.
Determination of when to extubate critically ill patients remains a high-stakes clinical challenge; and improved prediction of extubation failure has potential to save lives and reduce costs in critically ill patients.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
660
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 1Y6
- The University of British Columbia
-
-
Ontario
-
London, Ontario, Canada
- London Health Sciences Centre
-
Ottawa, Ontario, Canada, K1H 8L6
- The Ottawa Hospital
-
Ottawa, Ontario, Canada, K1Y 4W7
- University of Ottawa Heart Institute
-
Ottawa, Ontario, Canada
- The Ottawa Hospital-Civic Campus
-
Toronto, Ontario, Canada, M5B 1W8
- St. Michael's Hospital
-
Toronto, Ontario, Canada
- Mt Sinai
-
-
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-5048
- The University of Michigan Medical Center
-
-
Montana
-
Billings, Montana, United States, 59107
- Billings Clinic
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock Memorial Hospital
-
-
New York
-
New York, New York, United States, 10032
- Columbia University
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- University Hospitals of Cleveland
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-6205
- University of Pennsylvania
-
-
Utah
-
Salt Lake City, Utah, United States, 84107
- Intermountain Medical Center/University of Utah School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
ICU patients
Description
Inclusion Criteria:
- Invasive mechanical ventilation for >48 hours,
- patient is ready for SBTs for assessment for extubation,
- has a normal sinus rhythm at time of SBT (no pacemaker),
- is tolerating pressure support ventilation ≤14 cm H2O (SpO2 ≥ 90% with FiO2 ≤ 40% and PEEP ≤ 10 cm H2O),
- hemodynamically stable (low or no vasopressors), stable neurological status (no deterioration in GCS during prior 24 hours & ICP < 20),
- intact airway reflexes (cough & gag).
Exclusion Criteria:
- Order not to re-intubate,
- anticipated withdrawal of life support,
- known or suspected severe weakness (myopathy, neuropathy or quadriplegia),
- tracheostomy,
- and prior extubation during ICU stay.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Continuous heart rate (electrocardiogram) & respiratory rate (CO2 capnography) waveforms
Time Frame: at time of spontaneous breathing trial (at least 48 hours after intubation and within 24 hours of extubation)
|
at time of spontaneous breathing trial (at least 48 hours after intubation and within 24 hours of extubation)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Andrew Seely, MD, Ottawa Hospital Research Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Actual)
November 1, 2012
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
October 13, 2010
First Submitted That Met QC Criteria
November 9, 2010
First Posted (Estimate)
November 10, 2010
Study Record Updates
Last Update Posted (Actual)
July 7, 2017
Last Update Submitted That Met QC Criteria
July 5, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 2009-569
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mechanically Ventilated Patients
-
Fayoum University HospitalCompletedMechanically Ventilated PatientsEgypt
-
Makerere UniversityUnknownMechanically Ventilated PatientsUganda
-
ArcheonRecruitingMechanically Ventilated PatientsFrance
-
Damanhour UniversityNot yet recruitingMechanically Ventilated Patients
-
Wuhan Union Hospital, ChinaYichang Humanwell Pharmaceutical Co., Ltd., ChinaCompletedMechanically Ventilated PatientsChina
-
Assistance Publique - Hôpitaux de ParisTerminated
-
University Hospital, LimogesCompleted-Mechanically Ventilated PatientsFrance
-
Shaare Zedek Medical CenterUnknownMechanically Ventilated ICU PatientsIsrael
-
Bayside HealthCompletedMechanically Ventilated Patients | Intensive Care | Sedated PatientsAustralia
-
Laval UniversityCompletedCardiac Surgery | Mechanically Ventilated Patients